Drugs / Typhoid Conjugate vaccine
Typhoid Conjugate vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT06455852 | Mar 2025 → Dec 2028 expected | cholera | Massachusetts General Hospital | Recruiting | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 1/2 | NCT05480800 Comparator | Sep 2022 → Sep 2024 | salmonellosis | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT06879327 Background | May 2025 → Oct 2027 expected | Plasmodium falciparum malaria | PATH | Active not recruiting | No outcome recorded |
News releases announcing trial results or a regulatory action · 2
| Date | Issuer | Release |
|---|---|---|
| 2024-02-23 | SK Bioscience Co., Ltd. | Regulatory SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine skbioscience.com ↗
WHO PQ paves the way for public procurement by UN organizations. |
| 2018-01-03 | Bharat Biotech International Limited | Regulatory Typbar TCV®. from Bharat Biotech, World's First Typhoid Conjugate Vaccine Prequalified by WHO bharatbiotech.com ↗
Bharat Biotech’s Typbar TCV®, the world’s first clinically proven Typhoid Conjugate Vaccine against typhoid fever has received prequalification from World Health Organisation (WHO). |
All press releases naming this drug 5 releases
| Date | Issuer | Release |
|---|---|---|
| 2024-02-23 | SK Bioscience Co., Ltd. | SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine skbioscience.com ↗ |
| 2023-08-24 | SK Bioscience Co., Ltd. | SK bioscience and Vaxxas Enter Joint Development Agreement for Needle-Free Patch Delivery of Typhoid Vaccine skbioscience.com ↗ |
| 2020-12-17 | SK Bioscience Co., Ltd. | SK bioscience’s Typhoid Conjugate Vaccine Candidate Demonstrates Successful Phase III Clinical Trial Results skbioscience.com ↗ |
| 2020-02-17 | Biological E. Limited | K T RAMA RAO INAUGURATES BE’S PLANT AT GENOME VALLEY & UNVEILS TYPHOID CONJUGATE VACCINE biologicale.com ↗ |
| 2018-01-03 | Bharat Biotech International Limited | Typbar TCV®. from Bharat Biotech, World's First Typhoid Conjugate Vaccine Prequalified by WHO bharatbiotech.com ↗ |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Typhoid conjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05480800 ↗ |
| Known as | TCV | “The investigators will administer an OCV or typhoid vaccine (TCV) control and monitor antibody responses to identify better CoPs for cholera following both vaccination and...” NCT06455852 ↗ |
| Known as | typhoid vaccine | “The investigators will administer an OCV or typhoid vaccine (TCV) control and monitor antibody responses to identify better CoPs for cholera following both vaccination and...” NCT06455852 ↗ |
| Modality | Vaccine | “TCV low dose vaccine” NCT05480800 ↗ |